| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a056028050ba7dd8126057a1f425630a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84bae1e2d3c3a33be047241742fdfeb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e14df5c297ab0465c3d9ef25b667e990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8279f16bdfa9a8944aef3d330f8d523 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate |
1997-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f29bd4328c31f68fbbc9e861a95f842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0f6e163bd02cbc6ec4bc899a6df93e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b90e7e4e299dc011d94c104d9569af57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2968ce55b1e284213a5187712a11c964 |
| publicationDate |
1998-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2262422-A1 |
| titleOfInvention |
Programmed cell death and ich-3 |
| abstract |
This invention relates to modulation of programmed cell death. It also relates to transgenic non-human animals comprising a disrupted Ich-3 gene and methods of making these animals. The Ich-3 mutant animals exhibit resistance to septic shock and defects in folliculogenesis. This invention also relates to methods of using the transgenic animals to screen for compounds to treat septic shock and defective folliculogenesis. Moreover, this invention also relates to methods of treating septic shock in normal individuals by inhibiting ICH-3. |
| priorityDate |
1996-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |